| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/ATVBAHA.114.303034 |
| P698 | PubMed publication ID | 24743428 |
| P50 | author | Christopher D Byrne | Q38548520 |
| P2093 | author name string | Giovanni Targher | |
| P2860 | cites work | Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study. | Q51179884 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| liver disease | Q929737 | ||
| insulin resistance | Q1053470 | ||
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 1155-1161 | |
| P577 | publication date | 2014-04-17 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease | |
| P478 | volume | 34 |
| Q38346026 | Adipocytokines and hepatic fibrosis |
| Q92480030 | Assessment of left ventricular function in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease using three-dimensional speckle-tracking echocardiography |
| Q37710720 | Association between liver function and metabolic syndrome in Chinese men and women |
| Q94671574 | Association between muscle mass and insulin sensitivity independent of detrimental adipose depots in young adults with overweight/obesity |
| Q36334120 | Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis |
| Q55005271 | Being Metabolically Healthy, the Most Responsible Factor for Vascular Health. |
| Q91876988 | CHD is Associated With Higher Grades of NAFLD Predicted by Liver Stiffness |
| Q48103374 | Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH. |
| Q38711424 | Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease |
| Q26997059 | Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update |
| Q37633804 | Caryocar brasiliense oil improves cardiac function by increasing Serca2a/PLB ratio despite no significant changes in cardiovascular risk factors in rats |
| Q41483722 | Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism. |
| Q47158009 | Dietary Reference Values for choline |
| Q46466020 | Digestive system in psoriasis: an update |
| Q28085501 | Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome |
| Q88538398 | Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study |
| Q46185793 | Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. |
| Q53691000 | Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update. |
| Q35888143 | Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects |
| Q48140365 | Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. |
| Q36405082 | Gestational exercise protects adult male offspring from high-fat diet-induced hepatic steatosis. |
| Q39776464 | Gout and diabetes: a common combination |
| Q35126823 | Hepatokines as a Link between Obesity and Cardiovascular Diseases |
| Q34502294 | Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women |
| Q37149768 | Impact of Diabetes Mellitus |
| Q40959440 | Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation |
| Q35957448 | Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction |
| Q36806537 | MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways |
| Q28067490 | Metabolic aspects of adult patients with nonalcoholic fatty liver disease |
| Q38255049 | Metabolic syndrome and lifestyle modification |
| Q92776030 | Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-induced Weight Gain |
| Q38744017 | NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by 1 H-MRS? |
| Q47793060 | Non-obese fatty liver disease is associated with lacunar infarct. |
| Q33805278 | Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis |
| Q35740071 | Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes |
| Q35678746 | Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. |
| Q96954178 | Nonalcoholic fatty liver disease and cardiovascular disease phenotypes |
| Q49501260 | Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus |
| Q46424148 | Nonalcoholic fatty liver disease as a predictor of atrial fibrillation: a systematic review and meta-analysis |
| Q100946503 | Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors |
| Q89958068 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q90307768 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q55919856 | Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q64994493 | Pathological Implication of Adipocytes in AAA Development and the Rupture. |
| Q28550545 | Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization |
| Q93360900 | Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q57689012 | Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease |
| Q26767276 | Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis? |
| Q88524844 | Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease |
| Q92626901 | Senescent cells in the development of cardiometabolic disease |
| Q39410610 | The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment |
| Q64890915 | The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus. |
| Q47114074 | The relation between gallstone disease and cardiovascular disease |
| Q64237433 | Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study |
| Q42774743 | Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD. |
Search more.